Empyrean Capital Partners, LP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
Empyrean Capital Partners, LP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2014$13,062,000
-61.2%
309,821
-64.3%
0.74%
-37.5%
Q3 2014$33,661,000
+34.7%
868,000
+8.5%
1.19%
+35.2%
Q2 2014$24,984,000800,0000.88%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Raging Capital Management, LLC 295,790$1,367,0000.20%
Jump Trading, LLC 42,400$196,0000.06%
GAM Holding AG 83,940$388,0000.02%
Magnus Financial Group LLC 13,393$62,0000.01%
PANAGORA ASSET MANAGEMENT INC 438,606$2,026,0000.01%
Quantamental Technologies LLC 3,898$18,0000.01%
QS Investors, LLC 155,683$719,0000.01%
SFMG, LLC 11,994$55,0000.01%
Winslow, Evans & Crocker, Inc. 4,060$20,0000.01%
MILLENNIUM MANAGEMENT LLC 812,262$3,753,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders